Header Ads

Wuhan, all over again

Coronavirus Daily
Bloomberg

Here's the latest news:

It's all Wuhan

A few early cases of a worrying respiratory disease are identified. Government leaders say the risk is low and downplay the threat of spread.

More cases appear, but bottlenecks in testing mean it's hard to get an exact idea of how many people are actually infected. As diagnostic capacity rises, the government acknowledges the threat of the disease and puts in place never-before-contemplated restrictions on business and movement.

Hospitals begin to fill up, health-care workers get infected, and the death toll starts to rise.  

It's hard to tell the difference between the outbreak in China and the one in the U.S., isn't it?

Emergency Medical Technicians bring a patient into Wyckoff Hospital in Brooklyn, New York, on April 6.

Photographer: Bryan R. Smith/AFP via Getty Images

There are differences between the coronavirus epidemics in the two countries, but the similarities are depressingly similar.

In the latest unfortunate parallel, U.S. doctors who can't get access to tests to diagnose Covid-19 patients are turning to CT scans, using the infection's telltale damage to the lungs to confirm new cases. The same was done in China, where underequipped health workers had to use other criteria to try and track the disease. 

If you want to know how the outbreaks in the U.S. end, look to China. Only now, three months later, is Wuhan beginning to slowly open back up.

Epidemics follow patterns. Right now, the world is playing out the situation in Wuhan, over and over. The question is whether we get any better at it with every new iteration. Drew Armstrong

Listen Up

Latest Podcast: Hunting in the Sewage

A group of Dutch researchers may have discovered an early warning signal for where the virus is spreading. Jason Gale looks at the people testing the wastewater. That and the the latest headlines in 15 minutes.

Also: Map the outbreak around the world, and track Covid-19's spread in the U.S.

What you should read

Free Pass for Troubled Drugmakers

Faced with shortages, the U.S. is relaxing some import curbs.

Ballot Measures Take a Back Seat

Gathering signatures is nearly impossible in a time of lockdowns.

Zoom is the Pandemic's Social Network

"Every day is a record" as daily users climb to 200 million.

Europe Sees Weeks More of Lockdowns

Conte leaning toward early May, Spain extends until April 25.

EU Finance Chiefs Agree on $590 Billion in Aid 

EU must overcome political disagreements to approve the accord.

Know someone else who would like this newsletter?  Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments